• Thu news: Industry M&A volume down 8% over 2023. Pfizer’s Ibrance improves breast cancer survival. Lonza shedding capsule biz. AZ’s Lynparza in early breast cancer. Trump wants childhood vaccine discussion. See more on our front page

Oyster Point Pharma

Anonymous board for Oyster Point Pharma
Replies
87
Views
12K
anonymous
Replies
22
Views
2K
anonymous
Replies
4
Views
720
anonymous
Replies
36
Views
7K
anonymous
Replies
77
Views
15K
anonymous
Replies
23
Views
2K
anonymous
Replies
35
Views
6K
anonymous
Replies
33
Views
7K
anonymous
Replies
6
Views
4K
anonymous
Replies
31
Views
7K
anonymous
Replies
7
Views
2K
anonymous
Replies
2
Views
1K
anonymous
Replies
0
Views
517
anonymous
Replies
13
Views
5K
anonymous
Replies
19
Views
5K
anonymous
Replies
52
Views
11K
anonymous
Replies
23
Views
4K
anonymous
Replies
10
Views
2K
anonymous
Replies
42
Views
10K
anonymous